Biodesix, Inc. ( BDSX) - Key Metrics
BDSX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $2.61 | -$0.71 | -$0.15 | -$0.16 |
| 2026Q1 | $2.65 | -$0.81 | -$1.05 | -$1.07 |
| 2025Q4 | $3.57 | -$0.49 | $0.10 | $0.08 |
| 2025Q3 | $2.90 | -$1.16 | -$1.18 | -$1.19 |
| 2025Q2 | $2.73 | -$1.56 | -$0.90 | -$0.90 |
BDSX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -7.94 |
| 2026Q1 | 0% | -4.48 |
| 2025Q4 | 0% | -3.47 |
| 2025Q3 | 0% | -1.63 |
| 2025Q2 | 0% | -0.90 |
BDSX
Price: $26.18
52 week price:
Earnings Per Share: -3.02 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 306900
Market Capitalization: 213.1 million